BioAge Labs, Inc.
BIOA
$10.18
$0.9610.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.84% | 66.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.84% | 66.23% | |||
| Cost of Revenue | -6.71% | 78.63% | |||
| Gross Profit | 5.58% | -80.49% | |||
| SG&A Expenses | -8.97% | 8.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.32% | 51.89% | |||
| Operating Income | 6.58% | -50.62% | |||
| Income Before Tax | 6.46% | -66.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.46% | -66.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.46% | -66.79% | |||
| EBIT | 6.58% | -50.62% | |||
| EBITDA | 6.56% | -50.61% | |||
| EPS Basic | 6.47% | -66.81% | |||
| Normalized Basic EPS | 6.44% | -66.77% | |||
| EPS Diluted | 6.47% | -66.81% | |||
| Normalized Diluted EPS | 6.44% | -66.77% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||